XML 43 R33.htm IDEA: XBRL DOCUMENT
v3.24.3

Derivative Financial Instruments (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract] |
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value | The following table reflects the fair value amounts for designated and non-designated hedging instruments at September 30, 2024 and December 31, 2023 (in thousands):
| September 30, 2024 |  | December 31, 2023
Fair Value Derivative Assets(i) |  | Fair Value Derivative Liabilities(ii) |  | Fair Value Derivative Assets(i) |  | Fair Value Derivative Liabilities(ii)
Designated hedging instruments |  |  |  |  |  |  |
Foreign currency forward contracts | $ | 159 |  |  | $ | 351 |  |  | $ | 340 |  |  | $ | 44 |
Non-designated hedging instruments |  |  |  |  |  |  |
Foreign currency forward contracts | 112 |  |  | — |  |  | 146 |  |  | — |
Total fair value of hedging instruments | $ | 271 |  |  | $ | 351 |  |  | $ | 486 |  |  | $ | 44 |
_____________ (i)Included in prepaid expenses and other current assets on the condensed consolidated balance sheets. (ii)Included in accrued liabilities and other liabilities on the condensed consolidated balance sheets.
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) | The before-tax effects of derivative instruments designated as cash flow hedges on the accumulated other comprehensive loss and condensed consolidated statements of operations for the periods indicated below are as follows (in thousands):
| Three Months Ended September 30, |  | Nine months ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Amount of (loss) gain recognized in other comprehensive income (loss)(i) | $ | (385) |  |  | $ | (932) |  |  | $ | 148 |  |  | $ | 1,522 |
Amount of gain (loss) related to foreign exchange forward contracts reclassified from accumulated other comprehensive income (loss) into income(ii) | $ | 235 |  |  | $ | (7) |  |  | $ | 636 |  |  | $ | (1,511) |
_____________ (i)The before-tax loss of $385 re lated to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the three months ended September 30, 2024. The before-tax loss of $932 related to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the three months ended September 30, 2023. The before-tax gain of $148 re lated to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the nine months ended September 30, 2024. The before-tax gain of $1,522 related to foreign exchange forward contracts was recognized in other comprehensive income (loss) during the nine months ended September 30, 2023. (ii)The before-tax gains of $53 and $182 were inc luded in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations for the three months ended September 30, 2024. The before-tax losses of $2 and $5 were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations for the three months ended September 30, 2023. T he before-tax gai ns of $147 and $489 we r e included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on th e condensed consolidated statements of operations for the nine months ended September 30, 2024. The before-tax losses of $297 and $1,214 were included in cost of service revenues and operating expenses, primarily research and development expense, respectively, on the condensed consolidated statements of operations for the nine months ended September 30, 2023.
Schedule of Derivative Instruments, Gain (Loss) | The before-tax loss recognized in other (expense) income, net for non-designated foreign currency forward contracts for the periods indicated below are as follows (in thousands):
| Three Months Ended September 30, |  | Nine months ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Loss recognized in other (expense) income, net | $ | (42) |  |  | $ | (143) |  |  | $ | (73) |  |  | $ | (36) |

X
- References No definition available. + Details
Name: | us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4C -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C + Details
Name: | us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4E -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4E Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4C -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4C Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4A -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 815 -SubTopic 10 -Section 50 -Paragraph 4B -Publisher FASB -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4B + Details
Name: | us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration